ING Furman Selz Asset Management
2
34M
2
0.05
1
- Areas of investment
Summary
ING Furman Selz Asset Management is the famous Corporate Investor, which was founded in 1984. The leading representative office of defined Corporate Investor is situated in the New York. The company was established in North America in United States.
Among the most popular portfolio startups of the fund, we may highlight Achillion Pharmaceuticals. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular fund investment industries, there are Biotechnology, Therapeutics.
The high activity for fund was in 2002. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2006.
The standard case for the fund is to invest in rounds with 7-8 partakers. The meaningful sponsors for the fund in investment in the same round are Schroder Ventures, Regent Capital Partners, Pacific Growth Equities. In the next rounds fund is usually obtained by Quaker BioVentures, Pappas Ventures, Domain Associates.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.05
- Investments by industry
- Health Care (1)
- Pharmaceutical (1)
- Therapeutics (1)
- Biotechnology (1)
- E-Learning (1) Show 2 more
- Investments by region
-
- United States (2)
- Peak activity year
- 2002
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 28
- Group Appearance index
- 1.00
- Avg. company exit year
- 21
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.